CONMED Corp Files 8-K: Director Changes & Compensation Updates
Ticker: CNMD · Form: 8-K · Filed: Jul 7, 2025 · CIK: 816956
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-of-directors
Related Tickers: CNMD
TL;DR
CONMED board shakeup and comp changes filed today.
AI Summary
On July 7, 2025, CONMED Corporation filed an 8-K report detailing the departure of a director, the election of new directors, and updates to executive compensation arrangements. The filing also includes information on Regulation FD disclosures and financial statements, with the company incorporated in Delaware and headquartered in Largo, Florida.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns corporate governance and executive matters, which typically carry a lower immediate risk to the company's core business operations.
Key Players & Entities
- CONMED Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Largo, FL (location) — Principal executive offices
FAQ
What specific items are covered in the 8-K filing by CONMED Corporation?
The 8-K filing covers the departure of directors, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, in addition to Regulation FD disclosures and financial statements and exhibits.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 7, 2025.
What is CONMED Corporation's state of incorporation?
CONMED Corporation's state of incorporation is Delaware.
Where are CONMED Corporation's principal executive offices located?
CONMED Corporation's principal executive offices are located at 11311 Concept Blvd, Largo, FL 33773.
What is the SEC file number for CONMED Corporation?
The SEC file number for CONMED Corporation is 001-39218.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 7, 2025 regarding CONMED Corp (CNMD).